205 related articles for article (PubMed ID: 26106330)
1. Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy.
Graziani M; Nisticò R
Front Pharmacol; 2015; 6():122. PubMed ID: 26106330
[TBL] [Abstract][Full Text] [Related]
2. Methadone: a review of its pharmacokinetic/pharmacodynamic properties.
Garrido MJ; Trocóniz IF
J Pharmacol Toxicol Methods; 1999 Oct; 42(2):61-6. PubMed ID: 10924887
[TBL] [Abstract][Full Text] [Related]
3. Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.
Hanna J; Foster DJ; Salter A; Somogyi AA; White JM; Bochner F
Br J Clin Pharmacol; 2005 Oct; 60(4):404-13. PubMed ID: 16187972
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in pharmacokinetics and pharmacodynamics.
Beierle I; Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
[TBL] [Abstract][Full Text] [Related]
5. Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.
Rodriguez M; Carlos MA; Ortega I; Suarez E; Calvo R; Lukas JC
Pharm Res; 2002 Jun; 19(6):858-67. PubMed ID: 12134958
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.
Mitchell TB; White JM; Somogyi AA; Bochner F
Drug Alcohol Depend; 2003 Oct; 72(1):85-94. PubMed ID: 14563546
[TBL] [Abstract][Full Text] [Related]
7. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.
Shiran MR; Hosseinzadeh R; Hamidikenari A; Zarghami M; Lamsehchi N; Rafati MR
Iran J Psychiatry Behav Sci; 2011; 5(2):53-61. PubMed ID: 24644447
[TBL] [Abstract][Full Text] [Related]
9. Gender Differences in Heroin Addiction and Treatment: Results from the VEdeTTE Cohort.
Vigna-Taglianti FD; Burroni P; Mathis F; Versino E; Beccaria F; Rotelli M; Garneri M; Picciolini A; Bargagli AM;
Subst Use Misuse; 2016; 51(3):295-309. PubMed ID: 26872763
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of Methadone Response.
Fonseca F; Torrens M
Mol Diagn Ther; 2018 Feb; 22(1):57-78. PubMed ID: 29168075
[TBL] [Abstract][Full Text] [Related]
11. Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment.
Dennis BB; Bawor M; Paul J; Plater C; Pare G; Worster A; Varenbut M; Daiter J; Marsh DC; Desai D; Thabane L; Samaan Z
Curr Drug Abuse Rev; 2016; 9(1):49-60. PubMed ID: 27021147
[TBL] [Abstract][Full Text] [Related]
12. Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.
Yang F; Tong X; McCarver DG; Hines RN; Beard DA
J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):485-518. PubMed ID: 16758333
[TBL] [Abstract][Full Text] [Related]
13. Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services.
Leone B; Di Nicola M; Moccia L; Pettorruso M; De Risio L; Nucara G; Zamboni L; Callea A; Janiri L; Cibin M; Lugoboni F;
Addict Behav; 2017 Aug; 71():107-110. PubMed ID: 28327378
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral pharmacokinetic profile: a review of sex differences.
Ofotokun I; Chuck SK; Hitti JE
Gend Med; 2007 Jun; 4(2):106-19. PubMed ID: 17707845
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of methadone.
Lugo RA; Satterfield KL; Kern SE
J Pain Palliat Care Pharmacother; 2005; 19(4):13-24. PubMed ID: 16431829
[TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance at different dosages for opioid dependence.
Faggiano F; Vigna-Taglianti F; Versino E; Lemma P
Cochrane Database Syst Rev; 2003; (3):CD002208. PubMed ID: 12917925
[TBL] [Abstract][Full Text] [Related]
17. Review article: perioperative pain management of patients on methadone therapy.
Peng PW; Tumber PS; Gourlay D
Can J Anaesth; 2005 May; 52(5):513-23. PubMed ID: 15872131
[TBL] [Abstract][Full Text] [Related]
18. Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.
Song I; Mark S; Chen S; Savina P; Wajima T; Peppercorn A; Bala U; Geoffroy P; Piscitelli S
Drug Alcohol Depend; 2013 Dec; 133(2):781-4. PubMed ID: 24018316
[TBL] [Abstract][Full Text] [Related]
19. Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?
George R; Haywood A; Good P; Hennig S; Khan S; Norris R; Hardy J
Clin Ther; 2017 Sep; 39(9):1840-1848. PubMed ID: 28827023
[TBL] [Abstract][Full Text] [Related]
20. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.
Eap CB; Buclin T; Baumann P
Clin Pharmacokinet; 2002; 41(14):1153-93. PubMed ID: 12405865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
